Socho, ab hospitals jo medical devices aur kit-kits par itna markup laga dete hain na, us par lagaam lag sakti hai! India ki health ministry is par विचार kar rahi hai.
Hospitals Ke Bhaari Markup Par Action?
Ye koi mamuli baat nahi hai, kyunki report bata rahi hain ki kuch simple cheezein jaise syringe ko uski asli cost se 10 guna zyada becha jaa raha hai, aur pacemaker jaisi high-tech cheezein toh 800% tak mark up ho rahi hain! Health Ministry is baat par gaur kar rahi hai ki hospitals kitna trade margin charge kar sakte hain. 2018 mein NITI Aayog ne bhi suggestion diya tha ki ye markup 65% ke aas-paas ho, abhi jo discussions chal rahi hain usme ye figure 30% se 50% ke beech ho sakta hai. Isse patients par se bojh kam hoga aur hospital billing thodi transparent ho jayegi.
Insurers Ke Liye Tension Kyun?
Ye sab tab ho raha hai jab medical inflation already 11% se 15% tak chal rahi hai, jo normal inflation rate se kaafi zyada hai. Is wajah se health insurance premiums bhi aane wale 12-18 mahine mein 10-15% badhne wale hain. Agar family floater plans ki baat karein, toh ye ₹15,000 se badh kar ₹22,000 se upar pahunch gaye hain, matlab 46% ka increase. Insurers ka claims ratio bhi 90% se upar chala gaya hai, matlab lagbhag saara premium paisa claims mein hi jaa raha hai.
Investment Toh Aa Raha Hai!
Par is sab ke bawajood, healthcare aur insurance sector mein investment ki kami nahi hai. Jaise ki insurtech startup Plum ne recently ₹193 crore raise kiye hain. December 2025 se insurance sector mein 100% FDI bhi allowed ho jayega, jo aur paisa laane mein help karega.
Kya Ho Sakti Hai Problem?
Government ke price control wale kadam hamesha acche intention se liye jaate hain, par kabhi kabhi unintended consequences ho sakte hain. Aisa ho sakta hai ki quality gir jaaye, ya shayadospitals markup ko dusri services mein shift kar dein. Pehle bhi medical devices par price cap lagane ke efforts ke mix results rahe hain.
Market Ka Kya Scene Hai?
BSE Healthcare index ka P/E ratio abhi 38.6 hai aur Nifty Healthcare Index ka 36.8. Analysts expect kar rahe hain ki earnings growth around 21% ho sakti hai. Lekin, kuch analysts ab thode cautious ho gaye hain aur hospital stocks ke liye price targets bhi kam kar rahe hain kyunki margin pressure aur valuation ki chinta hai.
